Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01141192 · ClinicalTrials.gov registry record · NA

The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults

A NA study, sponsored by Augusta University.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT01141192 is a NA study that has completed, run by Augusta University. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01141192, a NA study, has completed, sponsored by Augusta University.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

Type 2 diabetes is more common among African Americans than Caucasians. African Americans are also at a higher risk for lower levels of vitamin D compared to other ethnic groups. The investigators don't yet know if there is a connection between not having enough vitamin D and type 2 diabetes in African Americans. Researchers have found that the less vitamin D Caucasians had the higher the chance they would have type 2 diabetes but it is less clear if this is the case for African Americans. The investigators want to better understand how vitamin D status and diabetes risk are linked in African Americans. Also, the investigators want to see if supplementation with vitamin D will improve your blood pressure, blood sugar, \& insulin. All of these are in some way related to diabetes. The investigators want to measure changes in blood sugar \& blood pressure in people who do not have diabetes with the hope of learning new information to help treat those that do have diabetes. The investigators hypothesize that vitamin D status is related to diabetes risk measured by hemoglobin A1c (a test of glucose level over time), fasting glucose and insulin in non-diabetic African American adults and that body weight status may affect vitamin D status in response to vitamin D supplements compared to placebo.

Interventions

  • DIETARY_SUPPLEMENT vitamin D3, cholecalciferol
  • DIETARY_SUPPLEMENT Inactive comparator

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2010-01
Est. Completion 2010-05
Phase NA

Sponsor

Augusta University

106 total trials

What the Registry Record Tells You About NCT01141192

The ClinicalTrials.gov registry entry for NCT01141192 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which vitamin D3, cholecalciferol is the first listed.

NCT01141192 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01141192 about?

NCT01141192 is a clinical study titled "The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults". Type 2 diabetes is more common among African Americans than Caucasians. African Americans are also at a higher risk for lower levels of vitamin D compared to other ethnic groups. The investigators don't yet know if there is a connection between not having enough vitamin D and type 2 diabetes in Afri...

What is the current status of trial NCT01141192?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2010-01. Estimated completion is 2010-05.

What interventions are being tested in trial NCT01141192?

The interventions under investigation include: vitamin D3, cholecalciferol (DIETARY_SUPPLEMENT), Inactive comparator (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01141192?

This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.